Radius Health (NASDAQ: RDUS) reported Q2 EPS of ($2.22), $1.33 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $10.62 million, versus $16.24 million reported last year.

For earnings history and earnings-related data on Radius Health (RDUS) click here.